Revenue
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $21.0M | $2.0M | — | — | — | — |
| Gross profit | $11.3M | $1.3M | — | — | — | — |
| Research & development | $67.0M | $72.1M | $30.7M | $28.0M | $15.5M | $9.4M |
| Operating expenses | $93.9M | $110.5M | $78.2M | $79.6M | $32.0M | $13.9M |
| Operating income | −$82.6M | −$109.2M | −$78.2M | −$79.6M | −$32.0M | −$13.9M |
| EBITDAderived | −$72.3M | −$100.9M | −$72.6M | −$77.0M | −$30.3M | −$12.2M |
| Net income | −$73.0M | −$100.2M | −$53.4M | −$51.0M | −$31.3M | −$13.9M |
| Basic EPSper diluted share | -$0.22 | -$0.31 | -$0.17 | -$0.18 | -$0.51 | -$0.23 |
| Diluted EPSper diluted share | -$0.22 | -$0.31 | -$0.17 | -$0.18 | -$0.51 | -$0.23 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 22, 2026Form 4 · 10b5-1 | Pilkington KyleCHIEF LEGAL OFFICER | SellClass A Common Stock | 25.0K | $1.20 | $30.0K | 1.02M |
| Mar 9, 2026Form 4 · 10b5-1 | Pilkington KyleCHIEF LEGAL OFFICER | SellClass A Common Stock | 25.0K | $1.20 | $30.0K | 780.2K |
| Jan 23, 2026Form 4 · 10b5-1 | Gan HongCHIEF SCIENCE OFFICER | SellClass A Common Stock | 100.0K | $2.50 | $250.0K | 1.25M |
| Jan 22, 2026Form 4 · 10b5-1 | Gan HongCHIEF SCIENCE OFFICER | SellClass A Common Stock | 150.0K | $2.50 | $375.0K | 1.25M |
| Dec 15, 2025Form 4 · 10b5-1 | Gan HongCHIEF SCIENCE OFFICER | SellClass A Common Stock | 100.0K | $1.98 | $198.0K | 1.25M |